HLA-C and breast cancer: Many solid tumors, including breast cancer, harbor chromosomal amplifications (9p24.1) of amplicons containing PD-L1 ligands [53] and structural translocation of class II transactivator (CIITA), which encodes MHC expression, to the PD-L1 gene leading to upregulatedPD-L1 expression [54].